What is OpiSafe?
The award-winning OpiSafe platform is engineered to comprehensively manage the opioid response for a diverse user base, including providers, patients, and first responders. Headquartered in Denver, OpiSafe has expanded its reach to serve customers in 42 states and provinces across the United States and Canada. Since its inception in 2012, OpiSafe's opioid prescribing platform has demonstrated substantial efficiency gains, saving small and large practices over 72,000 hours typically allocated to checking drug monitoring databases and assessing patients for risk, pain, and mental health.
How much funding has OpiSafe raised?
OpiSafe has raised a total of $825K across 3 funding rounds:
Private Equity
$500K
Debt
$150K
Debt
$175K
Private Equity (2015): $500K with participation from The Colorado Health Foundation
Debt (2020): $150K led by PPP
Debt (2021): $175K supported by PPP
Key Investors in OpiSafe
The Colorado Health Foundation
The Colorado Health Foundation is a prominent health-focused organization that likely invests in initiatives aimed at improving health outcomes and access to care, making OpiSafe a relevant portfolio company.
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for OpiSafe?
With a history of securing major enterprise-level funding and a recent strategic investment, OpiSafe is well-positioned for continued growth and expansion. The company's focus on streamlining opioid management and enhancing patient safety through technology indicates a strong market demand. Future developments are likely to involve further platform enhancements, broader market penetration, and potentially new strategic partnerships to amplify its impact in combating the opioid crisis.
See full OpiSafe company page
